SAFE-BioPharma Association has certified compliance with the US Department of Commerce and European Union Safe Harbor requirements for the protection of personal data. The non-profit association developed and manages the global SAFE-BioPharma® digital identity and signature standard, used within the biopharmaceutical and healthcare industries.
“Receiving Safe Harbor status assures SAFE-BioPharma member companies that use of the standard to manage digital identities and/or to apply digital signatures is consistent with E.U. regulations regarding data transfer and will further enhance our capabilities to better serve our European clients,” said Mollie Shields-Uehling, President and CEO, SAFE-BioPharma Association.
Details regarding E.U. Safe Harbor Principles are available at http://www.safe-biopharma.org/infocenter/SafeHarborOverview.pdf.
About SAFE-BioPharma Association (www.safe-biopharma.org) SAFE-BioPharma Association is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries.
The SAFE-BioPharma industry standard is used to mitigate legal, regulatory and other business risk associated with business-to-business and business-to-regulator electronic transactions. It facilitates interoperability by providing a secure, enforceable, and regulatory-compliant way to verify identities of parties involved in electronic transactions. Because the standard is linked to the Federal Bridge PKI Architecture through the 4BF (http://www.the4bf.com), a SAFE-BioPharma digital identity can be trusted by any Federal agency. SAFE-BioPharma’s vision is to be a catalyst in transforming the biopharmaceutical and healthcare communities to a fully electronic business environment by 2012.
The Association’s members include:
- Abbott (NYSE:ABT)
- Amgen (NASDAQ:AMGN)
- AstraZeneca (NYSE:AZN)
- Bristol-Myers Squibb (NYSE:BMY)
- GlaxoSmithKline (NYSE:GSK)
- Johnson & Johnson (NYSE:JNJ)
- Eli Lilly (NYSE:LLY)
- McDougall Scientific
- Merck (NYSE:MRK)
- National Notary Association
- Pfizer (NYSE:PFE)
- Premier Inc.
- Sanofi-Aventis (NYSE:SNY).
- ScheringPlough-Organon (NYSE:SGP)
- SNAP Diagnostics
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.